Subscribe to our newsletter and stay updated on the latest developments and special offers!

The journey of Takeda’s gout med Uloric—which turned rocky in recent years—has come to an end in the U.S. This week, the medicine, first approved in 2009, was listed as discontinued on the ...

Bone-chilling temperatures couldn’t keep the crowds away from Takeda’s Kendall Square campus on Tuesday to celebrate a milestone for the Japanese drugmaker’s new R&D tower. More than 250 ...

Takeda Canada Inc. (Takeda) is pleased to announce that Héma-Québec has added HyQvia®– (normal immunoglobulin [human] 10% and recombinant human hyaluronidase solution for subcutaneous ...

Three years after it was formed as a spinout of Japanese drugmaker Takeda, Phathom Pharmaceuticals has racked up its first FDA approvals, and claimed a sizeable $260 million in new financing to ...

Evox Therapeutics is the second UK biotech to sign a big deal with a pharma giant this week, snaring an $882 million partnership with Takeda for up to five rare disease programmes. The alliance ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Pedestrians wait for a street signal on a sidewalk as an electronic billboard shows the Shanghai and Shenzhen stock indexes in Shanghai, China January 21, 2025. REUTERS/Go Nakamura/File Photo Wall ...

Masayoshi Ōishi, Ayaka Nanase Perform New Themes for Yu-Gi-Oh! Go Rush!! Anime (Mar 18, 2024) Yu-Gi-Oh! Go Rush!! Anime Enters into 3rd Year in April 2024, Reveals New Visual (Dec 16, 2023) Yu-Gi ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...